These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38077094)

  • 1. Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index.
    Wade B; Pindale R; Camprodon J; Luccarelli J; Li S; Meisner R; Seiner S; Henry M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-brief right unilateral electroconvulsive therapy for the treatment of late-life bipolar disorder.
    Parker Schwab P; Dhingra A; Chapman H; Tan AC; McDonald WM; Riva-Posse P; Umair Janjua A; Job G; Hershenberg R; Hermida AP
    J Affect Disord; 2021 Jul; 290():197-201. PubMed ID: 34004401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.
    Singh B; Kung S; Pazdernik V; Schak KM; Geske J; Schulte PJ; Frye MA; Vande Voort JL
    J Clin Psychiatry; 2023 Feb; 84(2):. PubMed ID: 36724113
    [No Abstract]   [Full Text] [Related]  

  • 5. Individual response to electroconvulsive therapy is not correlated between multiple treatment courses.
    Hart KL; Henry ME; McCoy TH; Seiner SJ; Luccarelli J
    J Affect Disord; 2022 Feb; 298(Pt A):256-261. PubMed ID: 34742999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Electroconvulsive Therapy on Positive Affect and Hedonism in Patients With Depression: A Prospective Study.
    Crauwels B; Vansteelandt K; Obbels J; Lambrichts S; Pilato E; Demyttenaere K; Sienaert P
    J ECT; 2022 Jun; 38(2):110-116. PubMed ID: 34966039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report.
    Joseph B; Nunez NA; Kung S; Vande Voort JL; Pazdernik VK; Schak KM; Boehm SM; Carpenter B; Johnson EK; Malyshev G; Smits N; Adewunmi DO; Brown SK; Singh B
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
    Lipsitz O; McIntyre RS; Rodrigues NB; Kaster TS; Cha DS; Brietzke E; Gill H; Nasri F; Lin K; Subramaniapillai M; Kratiuk K; Teopiz K; Lui LMW; Lee Y; Ho R; Shekotikhina M; Mansur RB; Rosenblat JD
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110126. PubMed ID: 33031861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct trajectories of antidepressant response to intravenous ketamine.
    O'Brien B; Lijffijt M; Lee J; Kim YS; Wells A; Murphy N; Ramakrishnan N; Swann AC; Mathew SJ
    J Affect Disord; 2021 May; 286():320-329. PubMed ID: 33770540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
    McIntyre RS; Lipsitz O; Lui LMW; Rodrigues NB; Gill H; Nasri F; Ling R; Teopiz KM; Ho RC; Subramaniapillai M; Kratiuk K; Mansur RB; Jones BDM; Lee Y; Rosenblat JD
    J Affect Disord; 2021 Nov; 294():592-596. PubMed ID: 34332360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
    Fancy F; Rodrigues NB; Di Vincenzo JD; Chau EH; Sethi R; Husain MI; Gill H; Tabassum A; Mckenzie A; Phan L; McIntyre RS; Rosenblat JD
    Bipolar Disord; 2023 Mar; 25(2):99-109. PubMed ID: 36516343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment.
    Sakurai H; Hoeppner B; Jain F; Foster S; Pedrelli P; Mischoulon D; Fava M; Cusin C
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):140-145. PubMed ID: 35170480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.
    McIntyre RS; Rodrigues NB; Lee Y; Lipsitz O; Subramaniapillai M; Gill H; Nasri F; Majeed A; Lui LMW; Senyk O; Phan L; Carvalho IP; Siegel A; Mansur RB; Brietzke E; Kratiuk K; Arekapudi AK; Abrishami A; Chau EH; Szpejda W; Rosenblat JD
    J Affect Disord; 2020 Sep; 274():903-910. PubMed ID: 32664031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes of Electroconvulsive Therapy for Depressed Patients With and Without Borderline Personality Disorder: A Retrospective Cohort Study.
    Yip AG; Ressler KJ; Rodriguez-Villa F; Siddiqi SH; Seiner SJ
    J Clin Psychiatry; 2021 Jan; 82(2):. PubMed ID: 33471448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.
    Wang X; Chen Y; Zhou X; Liu F; Zhang T; Zhang C
    J ECT; 2012 Jun; 28(2):128-32. PubMed ID: 22622291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.